Reference pricing for drugs: Is it compatible with Korean health care system?

Published: 2012-06-25 06:58:00

Updated: 2012-06-25 06:58:00

- This article analyzes the impact of the reference pricing (RP) system on the Korea’s health insurance scheme, which has been recently reported to the Ministry of Health and Welfare by the Korea Drug Research Association.

To control spending on prescription drugs, health insurance systems abr...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK